Home › Categories › Government & Policy› FDA Tobacco Regulation

FDA Tobacco Regulation.pdf

FDACriticalAppraisalJune2023.pdf

🔗 Source: clivebates.com

📊 Size: 214 KB

📄 Pages: 4 pages

⬇️ Downloads: 104

Summary

The FDA's approach to tobacco and nicotine regulation is criticized for:
1. Lack of coherent regulatory strategy, with enormous barriers to entry for reduced-risk products.
2. Being hostile to innovation, approving low-nicotine cigarettes while denying safer alternatives like Juul.
3. Favoring big players, with smaller companies unable to afford the costs of Pre-market Tobacco Applications.
4. Providing wildly inaccurate regulatory impact analysis, underestimating costs and overestimating applications.
5. Having opaque decision-making criteria, with unclear standards for authorization or denial.
6. An authorization system leading to excessive caution and politicization, with rejected applications not based on public health reasons.
7. Adopting a simplistic view of youth risk behaviors, ignoring benefits of diverting young people from smoking to vaping.

Download File

Description

The FDA's approach to tobacco and nicotine regulation is criticized for:
1.

Technical Information

File Format: PDF
File Size: 214 KB
Pages: 4
Language: EN
Total Downloads: 104
Last Updated: 1 month ago

Document Overview

This PDF document about FDA Tobacco Regulation provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into FDA Tobacco Regulation.